Extended-release naltrexone overlooked in opioid use disorders guideline

被引：1
|
作者：
Rieb, Launette M. [1 ]
机构：
[1] Univ British Columbia, Fac Med, Dept Family Practice, Vancouver, BC, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2018年 / 190卷 / 28期
关键词：
RANDOMIZED CONTROLLED-TRIAL; BUPRENORPHINE-NALOXONE; MEDICATIONS; DEPENDENCE;
D O I：
10.1503/cmaj.69411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E862 / E862
页数：1
相关论文
共 50 条
  • [41] Extended-Release Naltrexone for Opioid Relapse Prevention at Jail Re-Entry
    Lee, Joshua D.
    McDonald, Ryan
    Santana-Correa, Nadina
    Rotrosen, John
    Gourevitch, Marc N.
    SUBSTANCE ABUSE, 2014, 35 (02) : 195 - 195
  • [42] Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder
    Lier, Audun J.
    Seval, Nikhil
    Vander Wyk, Brent
    Di Paola, Angela
    Springer, Sandra A.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 142
  • [43] Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians
    Randesi, Matthew
    Rotrosen, John
    Nunes, Edward, V
    Lee, Joshua D.
    Novo, Patricia
    Levran, Orna
    Ott, Jurg
    Pavlicova, Martina
    Scodes, Jennifer
    Kreek, Mary Jeanne
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2020, 46 (06): : 761 - 768
  • [44] Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT
    Strang, John
    Kelleher, Michael
    Mayet, Soraya
    Day, Ed
    Hellier, Jennifer
    Byford, Sarah
    Murphy, Caroline
    McLennan, Blair
    Shearer, James
    Ryan, Elizabeth
    Marsden, John
    HEALTH TECHNOLOGY ASSESSMENT, 2019, 23 (03) : 1 - +
  • [45] Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study
    Brenna, Ida Halvorsen
    Waleur, Karin Merethe
    Benth, Jurate Saltyte
    Solli, Kristin K.
    Mordal, Jon
    Loberg, Else-Marie
    Weimand, Bente
    Tanum, Lars
    EUROPEAN ADDICTION RESEARCH, 2025, 31 (01) : 1 - 12
  • [46] Combining a Candidate Vaccine for Opioid Use Disorders with Extended-Release Naltrexone Increases Protection against Oxycodone-Induced Behavioral Effects and Toxicity
    Raleigh, Michael D.
    Accetturo, Claudia
    Pravetoni, Marco
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2020, 374 (03): : 392 - 403
  • [47] Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
    Hoffman, Kim A.
    Baker, Robin
    Fanucchi, Laura C.
    Lum, Paula J.
    Kunkel, Lynn E.
    Terashima, Javier Ponce
    McCarty, Dennis
    Jacobs, Petra
    Korthuis, P. Todd
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
  • [48] Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
    Kim A. Hoffman
    Robin Baker
    Laura C. Fanucchi
    Paula J. Lum
    Lynn E. Kunkel
    Javier Ponce Terashima
    Dennis McCarty
    Petra Jacobs
    P. Todd Korthuis
    Addiction Science & Clinical Practice, 16
  • [49] Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial
    Bisaga, Adam
    Mannelli, Paolo
    Yu, Miao
    Nangia, Narinder
    Graham, Christine E.
    Tompkins, D. Andrew
    Kosten, Thomas R.
    Akerman, Sarah C.
    Silverman, Bernard L.
    Sullivan, Maria A.
    DRUG AND ALCOHOL DEPENDENCE, 2018, 187 : 171 - 178
  • [50] Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
    Ross, Rachael K.
    Nunes, Edward V.
    Olfson, Mark
    Shulman, Matisyahu
    Krawczyk, Noa
    Stuart, Elizabeth A.
    Rudolph, Kara E.
    ADDICTION, 2024, 119 (11) : 1975 - 1986
12345